Investing.com - Financial Markets Worldwide

HLB Life Science Co Ltd (067630)

KOSDAQ
Currency in KRW
3,520
-40(-1.12%)
Closed·
067630 Scorecard
Full Analysis
Management has been aggressively buying back shares
067630 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
3,4853,660
52 wk Range
3,46012,520
Key Statistics
Edit
Bid/Ask
3,520.00 / 3,525.00
Prev. Close
3,560
Open
3,565
Day's Range
3,485-3,660
52 wk Range
3,460-12,520
Volume
488.09K
Average Volume (3m)
593.03K
1-Year Change
-66%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
067630 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 13
RSI suggests the stock is in oversold territory
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

HLB Life Science Co Ltd Company Profile

HLB Life Science Co., Ltd. develops and manufactures in vitro diagnostic medical devices and quasi-drugs in South Korea and internationally. It also develops Rivoceranib, a small-molecule tyrosine kinase inhibitor for the treatment of various cancers, including gastric cancer, colon cancer, hepatocellular carcinoma, non-small cell lung cancer, breast cancer, mesothelioma, renal cell carcinoma, and neuroendocrine tumors; and Pyrotinib, an anticancer drug that inhibits the proliferation, division, and survival of cancer cells. In addition, the company is involved in the waste heat recovery, cogeneration power generation, facility installation, solar energy, photovoltaic power generation, bioenergy, geothermal energy, waste energy, wind power, and fuel cell businesses, as well as manufactures and sells disposable syringes. Further, the company also undertakes energy efficiency projects; and builds heating/heating system improvement projects, as well as renewable energy facility construction business. The company was formerly known as Energy Solutions Co., Ltd. and changed its name to HLB Life Science Co.,Ltd. in December 2015. HLB Life Science Co.,Ltd. was founded in 1998 and is headquartered in Hwaseong-si, South Korea.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
153
Market
South Korea

Compare 067630 to Peers and Sector

Metrics to compare
067630
Peers
Sector
Relationship
P/E Ratio
−5.6x12.8x−0.6x
PEG Ratio
0.010.000.00
Price/Book
1.4x1.4x2.6x
Price / LTM Sales
4.0x2.4x3.3x
Upside (Analyst Target)
-46.1%39.1%
Fair Value Upside
Unlock1.8%5.4%Unlock

Earnings

Latest Release
Aug 13, 2025
EPS / Forecast
-213.70 / --
Revenue / Forecast
11.77B / --
EPS Revisions
a
a
Unlock
Last 90 days

067630 Income Statement

FAQ

What Stock Exchange Does HLB Life Science Trade On?

HLB Life Science is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for HLB Life Science?

The stock symbol for HLB Life Science is "067630."

What Is the HLB Life Science Market Cap?

As of today, HLB Life Science market cap is 491.65B.

What Is HLB Life Science's Earnings Per Share (TTM)?

The HLB Life Science EPS (TTM) is -654.70.

From a Technical Analysis Perspective, Is 067630 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has HLB Life Science Stock Split?

HLB Life Science has split 4 times.

How Many Employees Does HLB Life Science Have?

HLB Life Science has 153 employees.

What is the current trading status of HLB Life Science (067630)?

As of 29 Aug 2025, HLB Life Science (067630) is trading at a price of 3,520, with a previous close of 3,560.00. The stock has fluctuated within a day range of 3,485 to 3,660, while its 52-week range spans from 3,460 to 12,520.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.